---
category: compliance
circular_id: c02ee1a91512c241
date: '2025-08-25'
description: SEBI issues order under Section 12(3) against Research Analyst Parag
  Salot (Registration No. INH000000115) for mis-selling services, fraudulent fund
  collection, and multiple regulatory compliance failures.
draft: false
guid: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={57D24B9A-C2C2-4856-BDFA-4DF5EB6CA9E3}&noticeno=20250825-1&dt=08/25/2025&icount=1&totcount=37&flag=0
impact: medium
impact_ranking: medium
importance_ranking: high
justification: Major regulatory enforcement action against research analyst for serious
  violations including fraud and mis-selling
pdf_url: https://www.bseindia.com/markets/MarketInfo/DownloadAttach.aspx?id=20250825-1&attachedId=12355d6b-2aac-4a36-ab87-aa178caaf8d5
processing:
  attempts: 1
  content_hash: 71638b72d9ca6d7d
  processed_at: '2025-08-25T12:51:24.571661'
  processor_version: '2.0'
  stage: completed
  status: published
published_date: '2025-08-25T05:34:34+00:00'
rss_url: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={57D24B9A-C2C2-4856-BDFA-4DF5EB6CA9E3}&noticeno=20250825-1&dt=08/25/2025&icount=1&totcount=37&flag=0
severity: high
source: bse
stocks: []
tags:
- research-analyst
- sebi-order
- fraudulent-practices
- regulatory-violations
- compliance-failures
- mis-selling
- assured-returns
- investment-advisory
title: SEBI Order Against Research Analyst Parag Salot for Fraudulent Practices and
  Regulatory Violations
---

## Summary

SEBI has issued an enforcement order against Research Analyst Parag Salot (Registration No. INH000000115, PAN: APEPS7000R) under Section 12(3) of the SEBI Act following an inspection covering April 2022 to February 2024. The order addresses serious violations including fraudulent practices, mis-selling of services with assured return promises, and systematic non-compliance with Research Analyst regulations.

## Key Points

- Research Analyst registered since March 2, 2015 found guilty of multiple regulatory violations
- Inspection period covered April 1, 2022 to February 29, 2024
- Two major categories of violations identified: fraudulent practices and regulatory non-compliance
- Violations include mis-selling services, fraudulent fund collection, and assured return promises
- Failed to maintain proper records of research recommendations provided to clients
- Conducted business without proper annual audits from FY 2014-15 to FY 2023-24
- Failed to comply with disclosure and transparency requirements

## Regulatory Changes

- Reinforces existing requirements under SEBI (Research Analysts) Regulations, 2014
- Emphasizes compliance with SEBI (Prohibition of Fraudulent and Unfair Trade Practices) Regulations, 2003
- Strengthens enforcement of intermediary registration and operational requirements

## Compliance Requirements

- Research Analysts must maintain detailed records of all recommendations provided to clients
- Annual audits are mandatory and must be conducted regularly
- Proper disclosure of registration details, office addresses required in all communications
- Website must display investor charter and complaint details
- Valid NISM certification required for conducting RA activities
- No assured returns or fraudulent promises allowed in client communications
- Immediate notification required for any change in office address

## Important Dates

- Registration Date: March 2, 2015
- Inspection Period: April 1, 2022 to February 29, 2024
- Inspection Findings Communicated: March 18, 2024
- Noticee Response: March 25, 2024
- Order Date: August 25, 2025

## Impact Assessment

This enforcement action serves as a strong warning to all Research Analysts regarding strict compliance with regulatory requirements. The case highlights SEBI's zero-tolerance approach toward fraudulent practices and mis-selling in the research analyst space. Market participants should expect increased scrutiny of research analyst operations, particularly regarding client communications, record-keeping, and compliance with disclosure requirements. The order reinforces investor protection measures and emphasizes the importance of transparent and ethical conduct in research services.